Open AccessRDNA-18. TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/p25: A NOVEL THERAPEUTIC APPROACH AGAINST GLIOBLASTOMA
Author(s) -
Émeline Tabouret,
Herui Wang,
Niranjana D. Amin,
Christophe E. Redon,
Jinkyu Jung,
Jing Cui,
Qi Song,
Limin Liu,
Romain Appay,
Anjali Vyas,
Deric Park,
Mark R. Gilbert,
Harish C. Pant,
Zhengping Zhuang
Publication year - 2018
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noy148.932
Subject(s) - temozolomide , apoptosis , dna damage , cyclin dependent kinase 5 , western blot , cell cycle , phosphorylation , chemistry , cancer research , peptide , pharmacology , microbiology and biotechnology , biology , glioblastoma , dna , biochemistry , cyclin dependent kinase 2 , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom